Tetramethylenedisulfotetramine

From WikiMD's WELLNESSPEDIA

Tetramethylenedisulfotetramine (TETS) is a potent neurotoxin that is used as a rodenticide. It is an odorless, tasteless white powder that is slightly soluble in water, ethanol, and acetone, and insoluble in benzene and ether. TETS is a member of the class of tetramines that is tetramine in which the nitrogens at positions 1, 3, 5, and 7 are each substituted by a methyl and a sulfonate group. It has a role as a rodenticide and a neurotoxin. It is a sulfonate ester, a member of tetramines and an organosulfonate. It derives from a hydride of a tetramine.

History[edit]

TETS was first synthesized in the 1950s and has been used as a rodenticide in many countries, including the United States, China, and Germany. However, due to its high toxicity and the difficulty of treating TETS poisoning, it has been banned in many countries.

Mechanism of Action[edit]

TETS is a non-competitive antagonist of the GABA(A) receptor, which means it binds to a site on the receptor that is distinct from the binding site for the endogenous neurotransmitter GABA. This binding inhibits the action of GABA, leading to an overexcitation of the central nervous system. This overexcitation can lead to seizures, respiratory failure, and death.

Symptoms of Poisoning[edit]

Symptoms of TETS poisoning can occur within minutes to hours after exposure and can include nausea, vomiting, abdominal pain, seizures, and coma. In severe cases, death can occur within hours due to respiratory failure.

Treatment[edit]

There is currently no specific antidote for TETS poisoning. Treatment is supportive and includes the control of seizures, maintenance of respiration, and the management of other symptoms as they occur.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.